LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 192 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $704,000 | -90.6% | 6,900 | -89.0% | 0.04% | -93.1% |
| Q2 2016 | $7,490,000 | +0.5% | 62,800 | -9.8% | 0.59% | +27.0% |
| Q1 2016 | $7,453,000 | +26.8% | 69,600 | +28.4% | 0.47% | -42.0% |
| Q4 2015 | $5,876,000 | +206.2% | 54,200 | +142.0% | 0.80% | +1772.1% |
| Q3 2015 | $1,919,000 | -8.7% | 22,400 | +7.5% | 0.04% | -21.8% |
| Q2 2015 | $2,102,000 | +37.7% | 20,834 | +5.3% | 0.06% | +44.7% |
| Q1 2015 | $1,526,000 | +67.5% | 19,789 | +2.1% | 0.04% | +58.3% |
| Q3 2014 | $911,000 | -12.2% | 19,380 | +16.4% | 0.02% | -14.3% |
| Q2 2014 | $1,037,000 | -36.8% | 16,655 | -56.1% | 0.03% | -37.8% |
| Q3 2013 | $1,641,000 | – | 37,907 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |